New insights into the role of sex steroid hormones in pregnancy: Possible therapeutic approach by sex steroid hormones for the treatment of both preeclampsia and preterm labor

Experimental and Clinical Endocrinology and Diabetes

Volumn 123, Issue 3, 2015, Pages 159-164

  Mizutani, S ^a   Mizutani, E ^a  

^a Daiya Building Ladys' Clinic   (Japan)

Author keywords

new role of sex steroid hormones in pregnancy; preeclampsia; preterm labor; sex steroid treatment

Indexed keywords

ANGIOTENSIN II; BETAMETHASONE; CORTICOSTEROID; CYTOSOL AMINOPEPTIDASE; ESTRADIOL BENZOATE; GLUTAMYL AMINOPEPTIDASE; HYDRALAZINE; MICROSOMAL AMINOPEPTIDASE; NICARDIPINE; NIFEDIPINE; PEPTIDE HORMONE; PLACENTAL LEUCINE AMINOPEPTIDASE; PROGESTERONE; RENIN; RITODRINE; SALBUTAMOL; SEX HORMONE; TRANSCRIPTION FACTOR AP 2; UNCLASSIFIED DRUG; VASOPRESSIN; CYSTYL AMINOPEPTIDASE; LEUCYL-CYSTINYL AMINOPEPTIDASE;

ARTICLE; CARDIOVASCULAR FUNCTION; DELIVERY; ENZYME DEGRADATION; FETOPLACENTAL UNIT; FETUS CIRCULATION; HOMEOSTASIS; HUMAN; NONHUMAN; PLACENTA; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; TROPHOBLAST; UPREGULATION; UTERUS CONTRACTION; FEMALE; METABOLISM; OBSTETRIC LABOR, PREMATURE; PHYSIOLOGY; PRE-ECLAMPSIA;

CYSTINYL AMINOPEPTIDASE; FEMALE; GLUTAMYL AMINOPEPTIDASE; GONADAL STEROID HORMONES; HUMANS; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY;

EID: 84925259353     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0034-1398622     Document Type: Article

References (63)

1. Broughton Pipkin F., Symonds E. M. Factors affecting angiotensin II concentrations in the human infant at birth. Clin Sci Mol Med: 1977; 52 449 456
2. Oosterbaan H. P., Swaab D. F. Amniotic oxytocin and vasopressin in relation to human development and labour. Early Hum Develop: 1989; 19 253 262
3. Iwasaki Y., Kinoshita M., Ikeda K. et al. Trophic effect of angiotensin II, vasopressin and other peptides on the cultured ventral spinal cord of rat embryo. J Neuro Sci: 1991; 103 151 155
4. Ervin M. G., Kullama L. K., Ross M. G. et al. Vasopressin receptors and effects during fetal development. Reg Peptide: 1993; 45 203 208
5. Sakura H., Lin T. Y., Doi M. et al. Purification and properties of oxytocinase, a metalloenzyme. Biochem Int: 1981; 2 173 179
6. Mizutani S., Sumi S., Oka R. et al. In vitro degradation of oxytocin by human placental subcellular fractions, pregnancy sera and purified placental aminopeptidases. Exp Clin Endocrinol: 1985; 86 310 316
7. Mizutani S., Okano K., Hasegawa E. et al. Aminopeptidase A in human placenta. Biochim Biophs Acta: 1981; 662 168 170
8. Mizutani S., Akiyama H., Kurauchi O. et al. In vitro degradation of angiotensin II (A-II) by human placental subcellular fractions, pregnancy sera and purified placental aminopeptidases. Acta Endocrinol: 1985; 110 135 139
9. Mizutani S., Naruse K., Hattori A. et al. Physiological and pathophysiological roles of placental aminopeptidase in maternal sera: possible relation to preeclampsia and preterm delivery. Expert Opin Med Diagn: 2009; 3 479 491
10. Phat V. N., Camilleri J. P., Bariety J. et al. Immunohistochemical characterizationof renin-containing cells in the human juxtaglomerular apparatus during embryonal and fetal development. Lab Invest: 1981; 45 387 390
11. Cheung C. Y. Fetal endocrinology. In Reece E. A., Hobbins J. C., Hahoney M. J., Petrie R. H. (eds.). Medicine of the fetus and mother. Philadelphia JB Lippincott: 1992; P. 155 172
12. Kingdam J. C., McQueeen J., Connell J. M. et al. Fetal angiotensin II levels and vascular (type I) angiotensin receptors in pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynecol: 1993; 100 476 482
13. DeVane G. W., Porter J. C. An apparent stress-induced release of arginine vasopressin by human neonates. J Clin Endocrinol Metab: 1980; 51 1412 1416
14. Mizutani S., Akiyama H., Kurauchi O. et al. Plasma angiotensin I and serum placental leucine aminopeptidase(P-LAP)in pre-eclampsia. Arch Gynecol: 1985; 236 165 172
15. Mizutani S., Yamada R., Kurauchi O. et al. Serum aminopeptidases A(APA) in normal pregnancy and pregnancy complicated by preeclampsia. Arch Gynecol. 1987; 240 27 31
16. Safwat A. M., Mizutani S., Salem H. T. et al. Changes of placental proteases, which degrade vasoactive peptides, in maternal sera at the onset of preeclampsia. Med Sci Res: 1995; 23 123 126
17. Kozaki H., Itakura A., Okamura M. et al. Maternal serum placental leucine aminopeptidase(P-LAP)/oxytocinase and preterm delivery. Int J Gynecol Obstet: 2001; 73 207 213
18. Chard T., Hudson C. N., Edwards C. R. et al. Release of oxytocin and vasopressin by the human foetus during labour. Nature: 1971; 234 352 354
19. Roberts R. M., Bazer F. W., Baldwin N. et al. Progesterone induction of lysozyme and peptidase activities in the porcine uterus. Arch Biochem Biophys: 1976; 177 499 507
20. Kurauchi O., Mizutani S., Nomura S. et al. Effects of progesterone and estradiol on aminopeptidases A(AAP) and leucine aminopeptidases (LAP) activities in the pregnancy serum and placenta of the rat. Exp Clin Endocrinol: 1989; 93 90 94
21. Miura S., Morita A., Erickson R. H. et al. Content and turnover of rat intestinal microvillus aminopeptidase-effect of methylpredonisolone. Gastroenterology: 1983; 85 1340 1349
22. Friedland J., Setton C., Siverstein E. Angiotensin converting enzyme: induction by steroids in rabbit alveolar macrophages in culture. Science: 1977; 197 64 65
23. Davis M. H. Hormonal regulationof dipeptidyl-aminopeptidase I activity in cultured human fibroblasts. Arch Biochem Biophs: 1987; 254 498 503
24. Yasuda Y., Mizutani S., Kurauchi O. et al. Induction by cortisol of aminopeptidases in tissue culture. Horm metab Res: 1992; 24 110 114
25. Diamant Y. Z., Neuman S., Shafrir E. Effects of chorionic gonadotropin, triamcinolone, progesterone and estrogen on enzymes of placenta and liver in rats. Biochem Biophys Acta: 1975; 385 257 267
26. Ino K., Goto S., Okamoto T. et al. Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by inhibition of aminopeptidase N activity. Jpn J Cancer Res: 1994; 85 927 933
27. Ringler G. E., Strauss III J. F. In vitro systems for the study of human placental endocrine function. Endocr Rev: 1990; 11 105 123
28. Katsumata Y., Nomura S., Ino K. et al. Progesterone stimulates the expression of aminopeptidase A/angiotensinase in human choriocarcinoma cells. Placenta: 2001; 22 831 836
29. Rogi T., Tsujimoto M., Nakazato H. et al. Human placental leucine aminopeptidase/oxytocinase. a new member of type II membrane-spanning zinc mettalopeptidase family. J Biol Chem: 1996; 271 257 261
30. Gergopoulos K., Moore D. D., Derfer B. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science: 1992; 258 808 812
31. Ito T., Nomura S., Okada M. et al. Transcriptional regulation of human placental leucine aminopeptidase/oxytocinase gene. Mol Hum Reprod: 2001; 7 887 894
32. Ito T., Nomura S., Okada M. et al. AP2 and Ikaros regulate transcription of human placental leucine aminopeptidase/oxytocinase gene. Biochem Biophys Res Commun: 2002; 290 1048 1053
33. Iwanaga K., Nomura S., Ito T. et al. Placental leucine aminopeptidase/oxytocinase gene regulation by activator protein-2 in BeWo cell model of human trophoblast differentiation. FEBS Lett: 2003; 552 120 124
34. Alexander D. P., Forsling M. I., Martin M. I. et al. The effect of maternal hypoxia on fetal pituitary hormone release in the sheep. Biol Neonate: 1972; 21 219 228
35. Bimbaumer M. Vasopressin receptors. Trends Endocrinol Metab: 2000; 11 406 410
36. Hariyama Y., Itakura A., Okamura M. et al. Placental aminopeptidase A as a possible barrier of angiotensin II between mother and fetus. Placenta: 2000; 21 621 627
37. Horio J., Nomura S., Okada M. et al. Structural organization of the 5′-end and chromosomal assignment of human placental leucine aminopeptidase/oxytocinase gene. Biochem Biophys Res Commun: 1999; 262 269 274
38. Johnson M. P., Fitzpatrick E., Dyer T. D. et al. Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. Mol Hum Reprod: 2007; 13 61 67
39. Hattori A., Matsumoto H., Mizutani S. et al. Molecular cloning of adipocyte-derived leucine aminopeptidase highly related to placental leucine aminopeptidase/oxytocinase. J Biochem: 1999; 125 931 938
40. Iwase A., Nomura S., Mizutani S. Characterization of a secretase activity for placental leucine aminopeptidase. Arch Biochem Biophys: 2001; 393 163 169
41. Ito N., Nomura S., Iwase A. et al. ADAMs, a disintegrin and metalloproteases, mediating shedding of oxytocinase. Biochem Biophys Res Commun: 2004; 314 1008 1013
42. Laigaard J., Sorensen T., Placing S. et al. Reduction of the disintegrin and metalloproteases ADAM12 in preeclampsia. Obstet Gynecol: 2005; 106 144 149
43. Gack S., Marme A., Marme F. et al. Preeclampsia: increased expression of soluble ADAM12. J Mol Med(Berl): 2005; 83 887 896
44. Smith G. V., Smith O. W. Estrogen and progestin metabolism in pregnancy. J Clin Endocrinol: 1941; 1 477 484
45. Hoover R. N., Hyer M., Pfeiffer R. M. et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med: 2011; 365 1304 1314
46. Mizutani S., Noto H., Inamoto Y. et al. Estimation of placental leucine aminopeptidase in abnormal pregnancy sera. Acta Obst Gynec Jpn: 1979; 31 493 498
47. Mizutani S., Kurauchi O., Ito Y. et al. Positive effect of estradiol and progesterone in severe preeclampsia. Exp Clin Endocrinol: 1988; 92 161 170
48. Sammour M. B., El-makhzangy M. N., Fawzy M. M. et al. Progesterone therapy in pregnancy induced hypertension: therapeutic value and hormonal profile. Clin Exp Hypertens B: 1982; 1 455 478
49. Sammour M. B., El-Kabarity H., Fawzy M. M. et al. Prevention and treatment of pregnancy-induced hypertension(preeclampsia) with progestogens. J Steroid Biochem Mol Biol: 2005; 97 439 440
50. Ryan K. J. Placental synthesis of steroid hormones. In: Tulchinsky D., Ryan K. J. (eds.). Maternal-fetal endocrinology. Philadelphia W.B. Saunders: 1980; 3 16
51. Naruki M., Mizutani S., Yamada R. et al. Changes in maternal serum oxytocinase activities in preterm labor. Med Sci Res: 1995; 23 797 802
52. Meis P. J., Klebanoff M., Thom E. et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone capronate. N Engl J Med: 2003; 348 2379 2385
53. Likis F. E., Valez Edwards D. R., Andrews J. C. et al. Progestogens for preterm birth prevention. Obst Gynec: 2012; 120 897 907
54. Rozenberg P., Chauveaud A., Derulle P. et al. Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone capronate: A randomized controlled trial. Am J Ob Gynec: 2012; 206 206.e1 206.e9
55. Mendelson C. R. Minireview: fetal-maternal hormonal signaling in pregnancy and labor. Mol Endocrinol: 2009; 23 947 954
56. Babischkin J. S., Grimes R. W., Pepe G. J. et al. Estrogen stimulation of P450 cholesterol side-chain cleavage activity in cultures of human placenta syncytiotrophoblasts. Biol Reprod: 1997; 56 272 278
57. Assali N. S., Clark K. E., Zugaib M. et al. Effects of estrogenic hormones on uteroplacental hemodynamics and progesterone production in the sheep. Int J Fertil: 1978; 23 219 223
58. Resnik R., Killam A. P., Battaglia F. C. et al. The stimulation of uterine blood flow by various estrogens. Endocrinology: 1974; 94 1192 1196
59. Matsuura S., Itakura A., Ohno Y. et al. Effects of estradiol on feto-placental growth in rat. Early Hum Develop: 2004; 77 47 56
60. Mizutani S., Tsunemi T., Mizutani E. et al. New insights into the role of aminopeptidases in the treatment for both preeclampsia and preterm labor. Expert Opin Investig Drugs: 2013; 22 1425 1436
61. McDonough P. G. Progesterone therapy: benefit versus risk. Fertil Steril: 1985; 44 13 16
62. Brown C. M., Garovic V. D. Mechanism and management of hypertension in pregnant women. Curr Hypertens Res: 2011; 13 338 346
63. Brown C. M., Garovic V. D. Drug treatment of hypertension in pregnancy. Drugs: 2014; 74 283 296